SOPHiA GENETICS is a cloud-native software company in the healthcare space dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-native platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by a broad global network of more than 750 hospitals, academic centers, laboratories, and biopharma institutions.

The SOPHiA DDM™ Platform allows users to upload data to the platform, select the relevant pipeline for analysis and the identification of variants and generate their report to support their analysis of cancer and rare diseases. When a customer uploads data, it not only benefits from the broad global network, but also from the statistical power of over 1.2 million genomic profiles already analyzed.

By this achievement SOPHiA GENETICS has earned recognition as one of MIT Technology Review’s 50 Smartest Companies in 2017 and SOPHiA GENETICS was named to Fast Company’s Annual List of the World’s Most Innovative Companies in 2023.

Our website provides more details and we are always open to discuss our extensive offerings.

www.sophiagenetics.com